Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-70,135
Closed -$12.2M 47
2017
Q4
$12.2M Sell
70,135
-11,720
-14% -$2.07M 2.07% 31
2017
Q3
$15.3M Sell
81,855
-20,760
-20% -$3.68M 2.2% 28
2017
Q2
$17.7M Buy
102,615
+600
+0.6% +$97.6K 2.07% 31
2017
Q1
$16.7M Sell
102,015
-5,855
-5% -$973K 1.96% 32
2016
Q4
$15.8M Sell
107,870
-1,955
-2% -$294K 1.88% 34
2016
Q3
$18.3M Sell
109,825
-1,100
-1% -$186K 2.12% 32
2016
Q2
$16.9M Sell
110,925
-7,475
-6% -$1.16M 1.95% 33
2016
Q1
$17.8M Sell
118,400
-11,893
-9% -$1.77M 1.94% 33
2015
Q4
$21.1M Sell
130,293
-41,075
-24% -$6.46M 2.14% 32
2015
Q3
$23.7M Sell
171,368
-23,350
-12% -$3.68M 1.97% 35
2015
Q2
$29.9M Sell
194,718
-43,412
-18% -$6.95M 2.05% 34
2015
Q1
$38.1M Sell
238,130
-125,791
-35% -$19.8M 2.13% 34
2014
Q4
$58M Sell
363,921
-147,999
-29% -$23.1M 2.69% 24
2014
Q3
$71.9M Sell
511,920
-140,375
-22% -$18.3M 2.89% 20
2014
Q2
$77.2M Buy
652,295
+326,197
+100% +$37.8M 2.63% 27
2014
Q1
$40.2M Sell
326,098
-16,750
-5% -$2.03M 1.27% 30
2013
Q4
$39.1M Sell
342,848
-26,025
-7% -$2.96M 1.17% 31
2013
Q3
$41.3M Buy
+368,873
New +$40M 1.26% 30

Other funds holding AMGN

Stralem & Co's AMGN Position: Q1 2018 in Review

Stralem & Co sold out of Amgen (AMGN) in Q1 2018, closing a stake of 70,135 shares — an estimated $12.2M sold.

Stralem & Co first reported a position in AMGN in Q3 2013 and held it in 18 quarters. The position peaked at $77.2M in Q2 2014. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Stralem & Co reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Stralem & Co sold 70,135 Amgen shares in Q1 2018, an estimated $12.2M.
  • Stralem & Co first reported a position in Amgen in Q3 2013 and held it in 18 quarters.
  • Stralem & Co's Amgen position peaked at $77.2M in Q2 2014.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Stralem & Co's 13F filing for Q1 2018, filed 19 Apr 2018.